Stock LOVE CANNARA BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cannara Biotech Inc. Canadian Securities Exchange

Equities

LOVE

CA13765U1012

Healthcare Facilities & Services

Delayed Canadian Securities Exchange
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Cannara Biotech Inc. -.--% +87.50%
Jan. 29 Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 CI
2023 Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 CI

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023
Capitalization 1 109.5 70.09 149 118.4 90.41
Enterprise Value (EV) 1 96.27 75.25 161.7 154.7 131.9
P/E ratio -7.74 x -5.43 x -85.1 x 135 x 12.9 x
Yield - - - - -
Capitalization / Revenue 52.2 x 27.5 x 8.75 x 3.3 x 1.58 x
EV / Revenue 45.9 x 29.5 x 9.5 x 4.32 x 2.3 x
EV / EBITDA -10.1 x -8.09 x 58.7 x 17.9 x 7.98 x
EV / FCF -3,920,257 x -4,323,521 x -4,799,164 x -6,579,097 x -12,045,507 x
FCF Yield -0% -0% -0% -0% -0%
Price to Book 2.32 x 1.83 x 2.32 x 1.77 x 1.13 x
Nbr of stocks (in thousands) 70,677 73,774 87,648 87,698 90,407
Reference price 2 1.550 0.9500 1.700 1.350 1.000
Announcement Date 11/28/19 12/15/20 12/8/21 11/25/22 12/7/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net sales 1 0.8653 2.097 2.551 17.02 35.84 57.26
EBITDA 1 -3.464 -9.497 -9.302 2.753 8.623 16.53
EBIT 1 -3.634 -9.922 -11.54 0.0526 4.819 11.72
Operating Margin -420.01% -473.16% -452.44% 0.31% 13.45% 20.46%
Earnings before Tax (EBT) 1 -4.226 -12.97 -13.09 -1.528 2.305 6.945
Net income 1 -4.226 -12.32 -12.48 -1.528 2.305 6.945
Net margin -488.38% -587.28% -489.35% -8.98% 6.43% 12.13%
EPS 2 -0.1171 -0.2003 -0.1750 -0.0200 0.0100 0.0778
Free Cash Flow - -24.56 -17.4 -33.7 -23.51 -10.95
FCF margin - -1,171.04% -682.31% -198.01% -65.59% -19.13%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/25/18 11/28/19 12/15/20 12/8/21 11/25/22 12/7/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net Debt 1 0.13 - 5.16 12.7 36.3 41.5
Net Cash position 1 - 13.3 - - - -
Leverage (Debt/EBITDA) -0.0367 x - -0.5551 x 4.626 x 4.207 x 2.511 x
Free Cash Flow - -24.6 -17.4 -33.7 -23.5 -11
ROE (net income / shareholders' equity) - -40.1% -29.7% -2.98% 3.52% 9.48%
ROA (Net income/ Total Assets) - -12.8% -11.7% 0.04% 2.77% 5.48%
Assets 1 - 96.28 106.4 -3,419 83.29 126.7
Book Value Per Share 2 0.3100 0.6700 0.5200 0.7300 0.7600 0.8800
Cash Flow per Share 2 0.2700 0.3800 0.1100 0.0900 0.1400 0.0500
Capex 1 27.9 23 9.18 31.1 15.1 9.31
Capex / Sales 3,226.58% 1,097.44% 359.94% 182.57% 42.12% 16.26%
Announcement Date 10/25/18 11/28/19 12/15/20 12/8/21 11/25/22 12/7/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Farming

1st Jan change Capi.
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 272M
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+33.74% 261M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+49.42% 194M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+44.98% 131M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M
INTERCURE LTD. Stock InterCure Ltd.
+115.91% 119M
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-42.17% 119M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
0.00% 86.82M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
Medical Farming
  1. Stock Market
  2. Equities
  3. LOVE Stock
  4. LOVE Stock
  5. Financials Cannara Biotech Inc.